| Treatment focus | Uses platelets from your own blood to support biological repair signaling. ReGen360’s treatment goals include improved comfort, mobility, and everyday function. | Delivers anti-inflammatory medication into the joint to relieve symptoms. | Builds strength, movement confidence, and function through individualized exercise. |
|---|
| Pain and function | Meta-analyses report meaningful improvements in knee osteoarthritis pain and function compared with placebo. [1] [2] | Can provide short-term pain relief, helping some patients participate in rehabilitation. | Exercise-based care is an important part of knee osteoarthritis management. |
|---|
| Patient selection | Earlier-stage knee osteoarthritis showed higher response rates in a clinical cohort. Your ReGen360 evaluation considers diagnosis, imaging, symptoms, and activity goals. [3] | Selection considers symptoms, prior response, injection frequency, and medical history. | The program is adapted to your strength, movement, symptoms, and health. |
|---|
| Preparation and duration | Platelet concentration can influence outcomes. Higher-concentration study groups showed sustained benefits through 12 months; discuss the preparation and plan suited to your condition. [1] | Duration varies. Follow-up helps determine whether another injection is appropriate. | Progressive exercise and continued participation support ongoing function. |
|---|
| Repeated treatment | PRP planning can include a series of injections and follow-up, tailored to the condition and clinical response. | Repeated use warrants care: a 2-year trial of 40 mg triamcinolone every 3 months found greater cartilage loss than saline, without better pain outcomes. This finding concerns that specific regimen. [5] | Exercises are progressed and adapted over time as strength and function improve. |
|---|
| Diabetes considerations | PRP itself is a steroid-free blood preparation. Your clinician reviews glucose control, medications, and overall suitability before treatment. | Can temporarily raise blood glucose, often 24–72 hours after injection. People with diabetes should arrange monitoring and medication guidance with their clinician. [6] | Exercise and activity plans can be coordinated with diabetes management. |
|---|
| Tolerability and aftercare | Generally well tolerated in reviewed trials, with reported reactions mainly temporary local discomfort. ReGen360 provides an individualized aftercare and follow-up plan. [4] | Temporary injection-site discomfort can occur. Review risks, repeat exposure, and aftercare with the clinician. | Activity is adjusted to keep exercise appropriate for symptoms and recovery. |
|---|
| Costs and coverage | Ask ReGen360 for an individualized plan and written estimate. Orthopedic PRP is often self-pay. | Coverage and out-of-pocket costs depend on the insurance plan and indication. | Coverage, visit limits, and out-of-pocket costs depend on the insurance plan. |
|---|